SAVA FY 2019 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$115M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$2M

Operating Income

-$5M

Net Income

-$5M

EPS (Diluted)

$-0.24

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$23M

Total Liabilities

$1M

Stockholders' Equity

$22M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$2M	-$69,000	-2172.5%
Operating Income	-$5M	-$7M	+25.6%
Net Income	-$5M	-$7M	+29.4%